# Effects of Metformin in a Non-Diabetic Patient Population

> **NCT03772964** · PHASE1,PHASE2 · COMPLETED · sponsor: **Brian Zuckerbraun** · enrollment: 32 (actual)

## Conditions studied

- Inflammatory Response

## Interventions

- **DRUG:** MetFORMIN Hydrochloride ER
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03772964
- **Lead sponsor:** Brian Zuckerbraun
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-22
- **Primary completion:** 2020-03-31
- **Final completion:** 2020-03-31
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2023-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03772964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03772964, "Effects of Metformin in a Non-Diabetic Patient Population". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03772964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*